Back
GT Biopharma, Inc. Stock Price Chart
$10K Investment in Nvidia Could've Made $2.5M
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
8
GTBP
GT Biopharma, Inc.
Last Price:
$0.52
Seasonality Move:
-5.56%
7 Day Trial
ALL ACCESS PASS
$
7
Most Pre-IPO Big Tech Shifts Look Like This at the Start
*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GTBP is experiencing buying pressure, which is a positive indicator for future bullish movement.
GT Biopharma, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.58 | Sell |
| 20-day SMA: | 0.66 | Sell |
| 50-day SMA: | 0.7 | Sell |
| 200-day SMA: | 1.43 | Sell |
| 8-day EMA: | 0.45 | Buy |
| 20-day EMA: | 0.28 | Buy |
| 50-day EMA: | 0.14 | Buy |
| 200-day EMA: | 0.04 | Buy |
GT Biopharma, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 37.16 | Sell |
| Chaikin Money Flow: | 963659 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.59 - 0.77) | Sell |
| Bollinger Bands (100): | (0.62 - 0.8) | Sell |
GT Biopharma, Inc. Technical Analysis
| Jan 26 | Jan 27 | Jan 28 | Jan 29 | Jan 30 | Feb 2 | Feb 3 | Feb 4 | Feb 5 | Feb 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | Feb | |||||||||
| 26 | 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for GT Biopharma, Inc. Stock
Is GT Biopharma, Inc. Stock a Buy?
-
GT Biopharma, Inc. share price is 0.54 while GTBP 8-day simple moving average is 0.58, which is a Sell signal.
-
The stock price of GTBP is 0.54 while GT Biopharma, Inc. 20-day SMA is 0.66, which makes it a Sell.
-
GT Biopharma, Inc. 50-day simple moving average is 0.70 while GTBP share price is 0.54, making it a Sell technically.
-
GTBP stock price is 0.54 and GT Biopharma, Inc. 200-day simple moving average is 1.43, creating a Sell signal.
GTBP Technical Analysis vs Fundamental Analysis
Sell
8
GT Biopharma, Inc. (GTBP)
is a Sell
Is GT Biopharma, Inc. a Buy or a Sell?
-
GT Biopharma, Inc. stock is rated a SellThe current GT Biopharma, Inc. [GTBP] share price is $0.54. The Score for GTBP is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
GT Biopharma, Inc. Stock Info
Market Cap:
5.7M
Price in USD:
0.54
Share Volume:
989.2K
GT Biopharma, Inc. 52-Week Range
52-Week High:
3.85
52-Week Low:
0.40
Sell
8
GT Biopharma, Inc. (GTBP)
is a Sell
GT Biopharma, Inc. Share Price Forecast
-
What is the GT Biopharma, Inc. stock price today?The GT Biopharma, Inc. stock price is 0.54 USD today.
-
Will GTBP stock go up or go down?GT Biopharma, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is GT Biopharma, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, GT Biopharma, Inc. is overvalued.
Is GT Biopharma, Inc. Stock a Buy?
-
GT Biopharma, Inc. share price is 0.54 while GTBP 8-day exponential moving average is 0.45, which is a Buy signal.
-
The stock price of GTBP is 0.54 while GT Biopharma, Inc. 20-day EMA is 0.28, which makes it a Buy.
-
GT Biopharma, Inc. 50-day exponential moving average is 0.14 while GTBP share price is 0.54, making it a Buy technically.
-
GTBP stock price is 0.54 and GT Biopharma, Inc. 200-day simple moving average is 0.04, creating a Buy signal.
Fundamental Analysis of GT Biopharma, Inc.
Is GT Biopharma, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.93 per share, and a decrease next year of $0.00 per share.
Technical Analysis of GT Biopharma, Inc.
Should I short GT Biopharma, Inc. stock?
-
GTBP Moving Average Covergence Divergence (MACD) indicator is 0.15, suggesting GT Biopharma, Inc. is a Buy
-
GT Biopharma, Inc. Relative Strength Index (RSI) is 37.16, which suggest GT Biopharma, Inc. is oversold
-
The Bollinger Bands (25) for GT Biopharma, Inc. is (0.59 - 0.77), which suggest GT Biopharma, Inc. is a Sell
-
The Bollinger Bands (100) for GT Biopharma, Inc. is (0.62 - 0.8), which suggest GT Biopharma, Inc. is a Sell
* GT Biopharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.